000 04481cam a2200577 i 4500
001 ocn930023615
003 OCoLC
005 20221128213007.0
006 m d
007 cr |||||||||||
008 150918s2015 nyu ob 001 0 eng
010 _a 2020686509
040 _aDLC
_beng
_erda
_cDLC
_dN$T
_dYDXCP
_dEBLCP
_dSTF
_dAU@
_dSCB
019 _a948511278
020 _a9781634839181
_qebook
020 _a1634839188
020 _z1634838785
_qhardcover
020 _z9781634838788
_qhardcover
035 _a1100292
_b(N$T)
035 _a(OCoLC)930023615
_z(OCoLC)948511278
072 7 _aMED
_x014000
_2bisacsh
072 7 _aMED
_x022000
_2bisacsh
072 7 _aMED
_x112000
_2bisacsh
072 7 _aMED
_x045000
_2bisacsh
049 _aMAIN
245 0 0 _aAcute myeloid leukemia :
_bsignssymptoms, classification, and treatment options
_c
_h[E-Book]
264 1 _aNew York :
_bNova Biomedical,
_c[2015]
300 _a1 online resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
490 1 _aCancer etiology, diagnosis and treatments
504 _aIncludes bibliographical references and index.
588 _aDescription based on print version record.
505 0 _aACUTE MYELOID LEUKEMIA SIGNS/SYMPTOMS, CLASSIFICATION AND TREATMENT OPTIONS ; ACUTE MYELOID LEUKEMIA SIGNS/SYMPTOMS, CLASSIFICATION AND TREATMENT OPTIONS ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 CLINICAL PRESENTATION OF ACUTE MYELOID LEUKEMIA ; ABSTRACT ; INTRODUCTION ; INCIDENCE AND PATIENT CHARACTERISTICS ; SYMPTOMS ; ORGAN INVOLVEMENT ; Skin ; Ocular ; Oral ; Central Nervous System ; Cardiovascular ; Pulmonary ; Gastrointestinal ; Lymphoreticular ; Musculoskeletal ; LABORATORY FINDINGS ; Complete Blood Counts ; Coagulation Studies
505 8 _aElectrolytes Leukocyte Larceny ; CLINICAL SYNDROMES ASSOCIATED WITH AML; Leukostasis ; Disseminated Intravascular Coagulation ; Tumor Lysis Syndrome ; Infection ; Extramedullary Disease ; CONCLUSION ; REFERENCES ; Chapter 2 PROGNOSIS OF CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA ; ABSTRACT ; INTRODUCTION ; Subtypes of CBF AML ; Clinical Prognostic Factors ; Molecular Prognostic Factors ; Cytogenetic Factors ; Minimal Residual Disease ; Other Factors ; CONCLUSION AND FUTURE PERSPECTIVES ; ACKNOWLEDGMENTS; REFERENCES; Chapter 3 PHILADELPHIA CHROMOSOME-POSITIVE ACUTE MYELOID LEUKEMIA
505 8 _aABSTRACT INTRODUCTION; Differentiating from Blast Phase Chronic Myeloid Leukemia ; ClinicopathologicFeatures ; Management ; Role of Chemotherapy ; Role of Tyrosine Kinase Inhibitors ; Allogeneic Stem Cell Transplantation ; Presence of Additional Abnormalities ; CONCLUSION ; CONFLICT OF INTEREST ; ACKNOWLEDGMENT ; REFERENCES ; Chapter 4 THERAPY OF OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA; ABSTRACT ; INTRODUCTION ; PROGNOSTIC FACTORS; Patient-Related Prognostic Factors ; Age ; Performance Status ; Comorbidities ; Other Patient-Related Prognostic Factors; Disease-Related Prognostic Factors
505 8 _aWBC Count Cytogenetics ; Molecular Genetics ; Mutations ; Overexpression ; Multidrug Resistance ; Secondary AML ; Other Disease Related Prognostic Factors ; Response-Related Prognostic Factors ; TREATMENT ; Intensive Induction Chemotherapy; The Role of Cytarabine ; The Role of Anthracycline ; The Role of Other Cytotoxic Agents ; The Role of Gemtuzumab Ozogamicin ; The Role of Multidrug Resistance Modulators ; The Role of Growth Factors ; Non-Intensive Induction Chemotherapy ; The Role of BSC ; The Role of Low Dose Cytarabine (LDAC) ; The Role of Clofarabine
505 8 _aThe Role of Hypomethylating Agents Azacitidine ; Decitabine ; Postremission Chemotherapy ; CONCLUSION; REFERENCES ; INDEX
590 _aMaster record variable field(s) change: 050, 082
650 0 _aAcute myeloid leukemia
_xDiagnosis.
650 0 _aAcute myeloid leukemia
_xTreatment.
700 1 _aGarza, Juan M.,
_eeditor.
830 0 _aCancer etiology, diagnosis, and treatments.
856 4 0 _uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=1100292
_yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
938 _aProQuest Ebook Central
_bEBLB
_nEBL4188992
938 _aYBP Library Services
_bYANK
_n12652335
938 _aEBSCOhost
_bEBSC
_n1100292
942 _n0
994 _a92
_bN$T
999 _c92326
_d92326